Physician profile
Virginia Lee
NPI 1740224229
$4,537.93
in general payments reported to CMS, 2019-2025
25 companies · $397 in 2025
The $397 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,153 · 2020: $320 · 2021: $984 · 2022: $537 · 2023: $468 · 2024: $678 · 2025: $397.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,443 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,443.42 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,074.93 | 2019-2022 | |
| Amgen INC. | $731.17 | 2019-2025 | Evenity, Prolia, Prolia |
| Mayne Pharma Commercial LLC | $659.42 | 2021-2025 | |
| Radius Health, INC. | $386.58 | 2019-2025 | Tymlos |
| Therapeuticsmd, INC. | $333.08 | 2019-2022 | |
| Avion Pharmaceuticals | $154.64 | 2021-2023 | Balcoltra |
| Astellas Pharma US INC | $126.03 | 2024-2025 | Veozah |
| Astrazeneca Pharmaceuticals LP | $124.18 | 2019 | |
| Hologic Sales and Service, LLC | $107.72 | 2019-2023 | Thinprep 2000 Processor, Aptima |
| Exeltis, USA INC. | $91.98 | 2024-2025 | Slynd |
| Minerva Surgical, INC | $90.88 | 2021 | |
| Pfizer INC. | $90.76 | 2019-2021 | |
| Coopersurgical, INC. | $87.86 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $83.67 | 2024 | Myfembree |
| Allergan, INC. | $78.14 | 2019-2020 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $67.51 | 2022 | |
| Evofem Biosciences, INC. | $48.16 | 2021-2022 | |
| Myovant Sciences INC. | $47.50 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $44.37 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $30.47 | 2021 | |
| Roche Diagnostics Corporation | $19.90 | 2019 | |
| Exact Sciences Corporation | $18.12 | 2023 | Cologuard Collection Kit |
| Lupin INC. | $15.02 | 2019 | |
| Daiichi Sankyo INC. | $14.45 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Virginia Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.